Antibiotics - The Perfect Storm

We need new antibiotics to fight infections caused by resistant bacteria. But the marketplace, the structure of the pharmaceutical industry, regulatory agencies, and difficult science are conspiring to deny us the products we need. This blog will present perspectives and developments in the fight for new antibiotics.

Wednesday, December 31, 2014

Antibiotics in 2014 - A Banner Year!

This year was a big year for antibiotics. The FDA approved four new antibiotics this year including dalbavancin and oritavancin, two long-a...

Wednesday, December 10, 2014

Antibiotics go Wild and Crazy!

This week Merck announced that it will acquire Cubist for $9.5 billion at a 35% premium over the stock price. Cubist is a mid-size pha...

Friday, December 5, 2014

FDA Beats Europe!

Today the FDA beat Europe on the antibiotics front for the first time in a long time. There was another advisory committee for ant...

Thursday, December 4, 2014

FDA and Resistant Infections - the Advisory Committee

Well, today was a big day for the FDA, or not, depending on how you look at things. The Advisory Committee met to discuss the FDA’s a...

Monday, November 24, 2014

Will FDA Strike Again?

On December 4 and 5, the FDA is gong to hold back-to-back advisory committee meetings. On Dec 4, the meeting will discuss clinical deve...

View web version

Powered by Blogger.